Anthill is now a Veeva AI Partner

Anthill, a leader in healthcare marketing, announces that they are now officially a Veeva AI partner. This is a recognition of Anthill’s innovative work in delivering AI content solutions in collaboration with the industry — and the company’s longstanding partnership with Veeva Solutions.

"By adding Anthill to our AI partner network, it helps our industry discover and re-use compliant personalized content faster. It empowers content creators to generate compliant material, using natural language to identify approved content for new targeted campaigns." Rob Best, Director Commercial Content Strategy, Veeva Systems

GenAI functionality built for pharma’s Veeva ecosystem

As a result of the partnership, Veeva customers will have the opportunity to apply Anthill’s forthcoming Arcane GenAI platform to their existing Veeva Promomats & MedComs content. This transforms their ability to discover, learn from, translate, create, and share content more effectively than ever before.  

“This is an important milestone that stresses the exciting journey we’re on with Veeva and their users. It also documents the groundbreaking work our tech team is doing to scale the use of GenAI in a pharma context” - Christian Dam, Chief Executive Officer, Anthill

Arcane – an enabler for pharma’s omnichannel ambitions  

Arcane will assist pharmaceutical companies in several important ways. It helps them quickly tackle strategic business questions and ensures that materials are delivered efficiently to local markets.

By breaking down barriers to content reuse, Arcane will empower companies to create new strategies using existing content modules and approved materials. Additionally, Arcane will streamline the process of assembling content and modules, making it easier to scale personalized and localized campaigns.

Built in collaboration with pharma

For Tor Kristensen , Anthill’s Chief Innovation Officer, it is vital that Arcane and its AI functionalities are built in close cooperation with the company’s longstanding pharma partners. According to Tor, this ensures the solutions address real-world problems from the start. It also means Arcane functionality will fit directly into pharma’s existing ecosystem.

Read more about Anthill's AI pharma solutions  

For media inquiries or further information about Arcane, please contact Mads Bjarni-Kornbech Senior Vice President, Marketing: mbk@anthillagency.com